NZ545440A - Meldonium salts, method of their preparation and pharmaceutical compositions on their basis - Google Patents
Meldonium salts, method of their preparation and pharmaceutical compositions on their basisInfo
- Publication number
- NZ545440A NZ545440A NZ545440A NZ54544004A NZ545440A NZ 545440 A NZ545440 A NZ 545440A NZ 545440 A NZ545440 A NZ 545440A NZ 54544004 A NZ54544004 A NZ 54544004A NZ 545440 A NZ545440 A NZ 545440A
- Authority
- NZ
- New Zealand
- Prior art keywords
- meldonium
- salts
- acid
- basis
- preparation
- Prior art date
Links
- PVBQYTCFVWZSJK-UHFFFAOYSA-N meldonium Chemical class C[N+](C)(C)NCCC([O-])=O PVBQYTCFVWZSJK-UHFFFAOYSA-N 0.000 title abstract 6
- 238000000034 method Methods 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 238000002360 preparation method Methods 0.000 title abstract 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 abstract 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 2
- 230000002045 lasting effect Effects 0.000 abstract 2
- 239000002904 solvent Substances 0.000 abstract 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 abstract 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical class CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 abstract 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 abstract 1
- 150000001450 anions Chemical class 0.000 abstract 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-M dihydrogenphosphate Chemical compound OP(O)([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-M 0.000 abstract 1
- 238000001704 evaporation Methods 0.000 abstract 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-M fumarate(1-) Chemical compound OC(=O)\C=C\C([O-])=O VZCYOOQTPOCHFL-OWOJBTEDSA-M 0.000 abstract 1
- 239000001530 fumaric acid Substances 0.000 abstract 1
- 229960002937 meldonium Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- -1 orotate anions Chemical class 0.000 abstract 1
- 150000007519 polyprotic acids Polymers 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000003756 stirring Methods 0.000 abstract 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
- C07C243/10—Hydrazines
- C07C243/12—Hydrazines having nitrogen atoms of hydrazine groups bound to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
- C07C243/10—Hydrazines
- C07C243/12—Hydrazines having nitrogen atoms of hydrazine groups bound to acyclic carbon atoms
- C07C243/14—Hydrazines having nitrogen atoms of hydrazine groups bound to acyclic carbon atoms of a saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
- C07C53/15—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing halogen
- C07C53/16—Halogenated acetic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
- C07C55/02—Dicarboxylic acids
- C07C55/06—Oxalic acid
- C07C55/07—Salts thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
- C07C55/02—Dicarboxylic acids
- C07C55/10—Succinic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
- C07C55/02—Dicarboxylic acids
- C07C55/14—Adipic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
- C07C57/13—Dicarboxylic acids
- C07C57/145—Maleic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
- C07C57/13—Dicarboxylic acids
- C07C57/15—Fumaric acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
- C07C59/08—Lactic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
- C07C59/265—Citric acid
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| LVP-03-88A LV13280B (en) | 2003-08-04 | 2003-08-04 | Sustained release salts of 3-(2,2,2-trimethylhydrazinium)propionate, a method of production and pharmaceutical compositions thereof |
| LVP-03-87A LV13279B (en) | 2003-08-04 | 2003-08-04 | Non-hygroscopic salts of 3-(2,2,2-trimethylhydrazinum)propionate,a method of production and pharmaceutical compositions thereof |
| PCT/LV2004/000005 WO2005012233A1 (en) | 2003-08-04 | 2004-07-15 | Meldonium salts, method of their preparation and pharmaceutical composition on their basis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ545440A true NZ545440A (en) | 2009-03-31 |
Family
ID=34118016
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ545440A NZ545440A (en) | 2003-08-04 | 2004-07-15 | Meldonium salts, method of their preparation and pharmaceutical compositions on their basis |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US7223797B2 (xx) |
| EP (1) | EP1667960B1 (xx) |
| JP (1) | JP4634380B2 (xx) |
| KR (1) | KR100745160B1 (xx) |
| AT (1) | ATE386014T1 (xx) |
| AU (1) | AU2004260779B2 (xx) |
| CA (1) | CA2535150C (xx) |
| DE (1) | DE602004011790T2 (xx) |
| DK (1) | DK1667960T3 (xx) |
| EA (1) | EA009083B1 (xx) |
| ES (1) | ES2302011T3 (xx) |
| HR (1) | HRP20080192T3 (xx) |
| IL (1) | IL173126A (xx) |
| MA (1) | MA28025A1 (xx) |
| MX (1) | MXPA06000955A (xx) |
| NO (1) | NO334623B1 (xx) |
| NZ (1) | NZ545440A (xx) |
| PL (1) | PL1667960T3 (xx) |
| PT (1) | PT1667960E (xx) |
| SI (1) | SI1667960T1 (xx) |
| UA (1) | UA82540C2 (xx) |
| WO (1) | WO2005012233A1 (xx) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LV13450B (en) * | 2004-08-24 | 2006-11-20 | Grindeks As | Novel medicinal use of meldonium and pharmaceutical compositions thereof |
| US10183001B1 (en) * | 2007-05-22 | 2019-01-22 | Pisgah Laboratories, Inc. | Opioid and attention deficit hyperactivity disorder medications possessing abuse deterrent and anti-dose dumping safety features |
| TW200930356A (en) * | 2007-12-04 | 2009-07-16 | Grindeks Jsc | New medical use of 3-(2,2,2-trimethylhydrazinium) propionate salts |
| ES2364017T3 (es) | 2007-12-05 | 2011-08-23 | Grindeks, A Joint Stock Company | Sales de propionato de 3-(2,2,2-trimethylhydrazinium) para el tratamiento del infarto de miocardio. |
| TWI391131B (zh) * | 2007-12-05 | 2013-04-01 | Grindeks Jsc | ３－（２，２，２－三甲基肼）丙酸鹽的新用途 |
| EP2067474A1 (en) | 2007-12-05 | 2009-06-10 | Grindeks, a joint stock company | Medical use of 3-(2,2,2-trimethylhydrazinium) propionate hydrogen fumarate |
| ATE527996T1 (de) | 2007-12-12 | 2011-10-15 | Grindeks Jsc | Medizinische verwendung von 3-(2,2,2- trimethylhydrazinium)propionat-orotat |
| WO2009095445A1 (en) * | 2008-01-29 | 2009-08-06 | Grindeks | New second medical use of 3-(2,2,2-trimethylhydrazine)propionate dihydrate |
| EP2247572B1 (en) * | 2008-02-19 | 2011-08-03 | Grindeks, a joint stock company | A one-pot process for preparing 3-(2,2,2-trimethylhydrazinium)propionate dihydrate |
| EP2128126A1 (en) * | 2008-05-26 | 2009-12-02 | Grindeks, a joint stock company | New process for the preparation of 3-(2,2,2-Trimethylhydrazinium) propionate dihydrate |
| WO2009144225A1 (en) * | 2008-05-26 | 2009-12-03 | Grindeks, A Joint Stock Company | New process for the preparation of 3-(2,2,2- trimethylhydrazinium) propionate dihydrate |
| CN102202651A (zh) * | 2008-10-29 | 2011-09-28 | 格林代克斯联合股份公司 | 3-(2,2,2-三甲基肼)丙酸盐二水合物的外用制剂 |
| LV14230B (lv) * | 2009-04-30 | 2011-05-20 | Latvijas Organiskās Sintēzes Institūts | Farmaceitiska kompozīcija Parkinsona slimības profilaksei un ārstēšanai |
| EP2445861B1 (en) * | 2009-06-25 | 2014-03-26 | Tetra, Sia | Novel acetylsalicylic acid salts |
| LV14274B (lv) * | 2009-06-25 | 2011-03-20 | Grindeks, A/S | Meldoniju saturošs kombinēts medicīniskais produkts |
| WO2010149654A1 (en) * | 2009-06-25 | 2010-12-29 | Grindeks, A Joint Stock Company | Pharmaceutical composition of gamma-butyrobetaine or a pharmaceutically acceptable salt and meldonium or a pharmaceutically acceptable salt |
| LV14268B (lv) * | 2009-06-25 | 2011-03-20 | Grindeks, A/S | Meldonija sukcinātu saturoši medicīniskie produkti |
| EP2399904A1 (en) * | 2010-05-26 | 2011-12-28 | Nabriva Therapeutics AG | Process for the preparation of pleuromutilins |
| EP2420224A1 (en) * | 2010-08-11 | 2012-02-22 | Grindeks, a joint stock company | Method for producing a stable 3-(2,2,2-trimethylhydrazinium)propionate dihydrate solid pharmaceutical composition |
| GEP20156373B (en) * | 2011-04-27 | 2015-09-25 | Grindeks Jsc | Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium salts in the treatment of cardiovascular disease |
| RU2457198C1 (ru) * | 2011-05-31 | 2012-07-27 | Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" | Производное 3-(2,2,2-триметилгидразиний)пропионата - глицинат 3-(2,2,2-триметилгидразиний)пропионат калия, обладающее противоишемической активностью |
| RU2458690C1 (ru) * | 2011-05-31 | 2012-08-20 | Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" | Производное 3-(2,2,2-триметилгидразиний) пропионата - 5-бромникотинат 3-(2,2,2-триметилгидразиний) пропионат калия, обладающее противоишемической активностью |
| RU2467745C1 (ru) * | 2011-08-08 | 2012-11-27 | Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" | Производное 3-(2,2,2-триметилгидразиний) пропионата - 5-бромникотинат 3-(2,2,2-триметилгидразиний) пропионат калия, обладающее эндотелиопротекторной активностью |
| RU2467744C1 (ru) * | 2011-08-08 | 2012-11-27 | Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" | Производное 3-(2,2,2-триметилгидразиний) пропионата - 5-гидрокисиникотинат 3-(2,2,2-триметилгидразиний) пропионат калия, обладающее эндотелиопротекторной активностью |
| RU2485953C1 (ru) * | 2012-04-12 | 2013-06-27 | Общество с ограниченной ответственностью "Научно-внедренческий центр Агроветзащита" | Комплекс 3-(2,2,2-триметилгидразиний) пропионат-2-этил-6-метил-3-гидроксипиридина дисукцинат, обладающий антигипоксическим и адаптогенным действием, и способ его получения |
| LV14848B (lv) * | 2012-10-25 | 2015-06-20 | Latvijas Organiskās Sintēzes Institūts | Farmaceitiska kompozīcija trimetilamīna-N-oksīda līmeņa pazemināšanai |
| RU2527347C1 (ru) * | 2013-03-12 | 2014-08-27 | Общество с ограниченной ответственностью "Научно-внедренческий центр "Агроветзащита" | Стабильная жидкая фармацевтическая композиция комплекса 3-(2,2,2-триметилгидразиний) пропионат-2-этил-6-метил-3-гидроксипиридина дисукцината, обладающая антигипоксическим, антиоксидантным и адаптогенным действием |
| EP2842557A1 (en) * | 2013-08-30 | 2015-03-04 | SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. | Mildronate in ophthalmic disorders |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU997646A1 (ru) * | 1978-11-27 | 1983-02-23 | Ордена Трудового Красного Знамени Институт Органического Синтеза Ан Латвсср | Кормова добавка |
| SU978808A1 (ru) * | 1980-01-18 | 1982-12-07 | Ордена Трудового Красного Знамени Институт Органического Синтеза Ан Латвсср | Способ регулировани роста растений люпина |
| SU1680693A1 (ru) * | 1987-03-25 | 1991-09-30 | Институт Органического Синтеза Ан Латвсср | Этил-3-(2,2-диметил-2-этилгидразиний)пропионат иодистый, про вл ющий антиаритмическую активность |
| EP0307977B1 (en) * | 1987-09-07 | 1992-09-30 | Teikoku Tsushin Kogyo Co. Ltd. | Molded resin casing of electronic part with flat cable |
| LV11727B (en) | 1995-08-21 | 1997-08-20 | Kalvins Ivars | Pharmaceutical composition |
-
2004
- 2004-07-15 UA UAA200601710A patent/UA82540C2/uk unknown
- 2004-07-15 CA CA2535150A patent/CA2535150C/en not_active Expired - Fee Related
- 2004-07-15 EP EP04748553A patent/EP1667960B1/en not_active Expired - Lifetime
- 2004-07-15 SI SI200430711T patent/SI1667960T1/sl unknown
- 2004-07-15 AU AU2004260779A patent/AU2004260779B2/en not_active Ceased
- 2004-07-15 NZ NZ545440A patent/NZ545440A/xx not_active IP Right Cessation
- 2004-07-15 DE DE602004011790T patent/DE602004011790T2/de not_active Expired - Lifetime
- 2004-07-15 PT PT04748553T patent/PT1667960E/pt unknown
- 2004-07-15 JP JP2006522512A patent/JP4634380B2/ja not_active Expired - Fee Related
- 2004-07-15 ES ES04748553T patent/ES2302011T3/es not_active Expired - Lifetime
- 2004-07-15 WO PCT/LV2004/000005 patent/WO2005012233A1/en not_active Ceased
- 2004-07-15 KR KR1020067002265A patent/KR100745160B1/ko not_active Expired - Fee Related
- 2004-07-15 PL PL04748553T patent/PL1667960T3/pl unknown
- 2004-07-15 EA EA200600175A patent/EA009083B1/ru unknown
- 2004-07-15 AT AT04748553T patent/ATE386014T1/de active
- 2004-07-15 MX MXPA06000955A patent/MXPA06000955A/es active IP Right Grant
- 2004-07-15 HR HR20080192T patent/HRP20080192T3/xx unknown
- 2004-07-15 US US10/567,130 patent/US7223797B2/en not_active Expired - Lifetime
- 2004-07-15 DK DK04748553T patent/DK1667960T3/da active
-
2005
- 2005-12-09 NO NO20055867A patent/NO334623B1/no not_active IP Right Cessation
-
2006
- 2006-01-12 IL IL173126A patent/IL173126A/en not_active IP Right Cessation
- 2006-03-03 MA MA28856A patent/MA28025A1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EA009083B1 (ru) | 2007-10-26 |
| CA2535150C (en) | 2010-04-13 |
| ES2302011T3 (es) | 2008-07-01 |
| MXPA06000955A (es) | 2006-03-30 |
| EP1667960B1 (en) | 2008-02-13 |
| WO2005012233A8 (en) | 2005-05-19 |
| UA82540C2 (uk) | 2008-04-25 |
| NO20055867L (no) | 2006-02-27 |
| US7223797B2 (en) | 2007-05-29 |
| HRP20080192T3 (hr) | 2008-05-31 |
| IL173126A0 (en) | 2006-06-11 |
| DE602004011790D1 (de) | 2008-03-27 |
| EA200600175A1 (ru) | 2006-08-25 |
| IL173126A (en) | 2011-02-28 |
| AU2004260779B2 (en) | 2009-01-22 |
| DE602004011790T2 (de) | 2009-03-05 |
| PL1667960T3 (pl) | 2008-06-30 |
| US20060264506A1 (en) | 2006-11-23 |
| AU2004260779A1 (en) | 2005-02-10 |
| MA28025A1 (fr) | 2006-07-03 |
| CA2535150A1 (en) | 2005-02-10 |
| NO334623B1 (no) | 2014-04-28 |
| DK1667960T3 (da) | 2008-06-09 |
| WO2005012233A1 (en) | 2005-02-10 |
| KR20060059995A (ko) | 2006-06-02 |
| JP2007501222A (ja) | 2007-01-25 |
| HK1093197A1 (zh) | 2007-02-23 |
| JP4634380B2 (ja) | 2011-02-16 |
| PT1667960E (pt) | 2008-05-02 |
| KR100745160B1 (ko) | 2007-08-01 |
| EP1667960A1 (en) | 2006-06-14 |
| ATE386014T1 (de) | 2008-03-15 |
| SI1667960T1 (sl) | 2008-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA06000955A (es) | Sales de meldonio, metodo para su preparacion y composiciones farmaceuticas basadas en ellas. | |
| JP7536721B2 (ja) | キナーゼを修飾する１ｈ－ピロロ［２，３－ｂ］ピリジン誘導体の合成 | |
| US20090118238A1 (en) | Deuterium-enriched alendronate | |
| DK164543B (da) | Salte af l-carnitin og alkanoyl-l-carnitiner, fremgangsmaade til deres fremstilling og farmaceutiske kompositioner indeholdende forbindelserne | |
| TW201209049A (en) | Chemical compounds | |
| BRPI0607379B1 (pt) | composição farmacêutica de efeito analgésico | |
| WO2016192692A1 (en) | Solid forms of tenofovir alafenamide | |
| Ananchenko et al. | Alendronate sodium | |
| WO1999002500A1 (es) | Resolucion de aminas | |
| US4034086A (en) | Pyrrolidone-5,5-diphosphonic acids | |
| JP2012500778A5 (xx) | ||
| JPH0363541B2 (xx) | ||
| CA2754390A1 (en) | Methods for the preparation of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)ethyl]phosphonic acid and precursors thereof | |
| Chen et al. | Structure-activity relationships in a series of 5-[(2, 5-dihydroxybenzyl) amino] salicylate inhibitors of EGF-receptor-associated tyrosine kinase: importance of additional hydrophobic aromatic interactions | |
| CN117343052B (zh) | 蛋白酪氨酸磷酸酶抑制剂及其应用 | |
| SK1752002A3 (en) | Nitroxy derivatives of (r) and (s)-carnitine | |
| HU212494B (en) | Process for producing new tetraline derivatives and pharmaceutical compositions containing them as active components | |
| US20080139845A1 (en) | Ibandronate sodium propylene glycol solvate and processes for the preparation thereof | |
| HU195811B (en) | Process for producing 6-aryl-11h-pyrido/2,3-b//1,4/benzodiazepine derivatives | |
| PL90714B1 (xx) | ||
| JPH0798777B2 (ja) | ２，２−ジハロ−１，４−ジアミノブタン化合物及び製薬上受入れられるその塩 | |
| Ryan et al. | Development of a Nucleotide Prodrug of 4’-Fluorouridine to Improve Tolerability | |
| RU2722717C1 (ru) | Способ получения N6-ди(перфторалкокси)фосфорилсиднониминов | |
| HU196159B (en) | Process for producing aphidicolin derivatives and pharmaceutics comprising the same as active ingredient | |
| CN119095829A (zh) | 用于制备4-[5-[双(2-氯乙基)氨基]-1-甲基-1H-苯并[d]咪唑-2-基]丁酸烷基酯和甲酰化衍生物的方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) | ||
| RENW | Renewal (renewal fees accepted) | ||
| LAPS | Patent lapsed |